Cadence and Providence launch remote patient monitoring program advancing quality and access to care for patients at home | Read more

Cadence Style Guide

Headings

H1

H2

H3

H4

H5

H6

Body Text

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Buttons

Connect with Cadence

Cadence results

A win-win for patients, clinicians, and health systems

Cadence for clinicians

of enrolled patients take their vitals with Cadence 16+ days per month¹

¹Cadence results across 7 U.S. states

Only 1% of virtual encounters escalate to physicians¹

¹Cadence results as measured by inbox messages in partner EMRs

reduction in the number of patients seen in the emergency department¹

¹Based on the longest lasting cohort of cHF patients enrolled in Cadence. The number of unique patients who visited the emergency room declined by 50%; the number of unique patients with emergency room visits is normalized for patient tenure in the program.

. . .

With Cadence

WITHouT CADENCE

5.5

increase in patient adherence to guideline-directed therapies¹

“Cadence Data Improved Outcomes for Heart Failure Patients”

decrease in no-show rates for our partner clinics¹

¹Cadence results in North Carolina

of patients feel more connected and supported by their providers since enrolling¹

¹Cadence patient surveys

Cadence results

Cadence heart failure patients are 5.5x more likely to be on all four pillars of GDMT

Review our latest clinical results presented at the 2022 Heart Failure Society of America

With Cadence

WITHouT CADENCE

5.5

increase in the percentage of patients on all four pillars of GDMT at follow-up (39%) compared to baseline (7%)

“Cadence Data Improved Outcomes for Heart Failure Patients.”

With Cadence

WITHouT CADENCE

Increase in the percentage of patients on sodium glucose co-transporter 2 inhibitors (SGLT2i) at follow-up (53%) compared to baseline (18%)

“Cadence Data Improved Outcomes for Heart Failure Patients”

With Cadence

WITHouT CADENCE

A significant increase in the percentage of patients on >50% target dose of GDMT for each pillar other than beta blockers

“Cadence Data Improved Outcomes for Heart Failure Patients.”

With Cadence

WITHouT CADENCE

1.5

increase in the percentage of patients on mineralocorticoid receptor antagonist (MRA) at follow-up (65%) compared to baseline (42%)

“Cadence Data Improved Outcomes for Heart Failure Patients.”